COMMUNIQUÉS West-GlobeNewswire

Veloxis to Host Conference Call Following Release of Interim Financial Report for the Period 1 January to 30 June 2019
06/08/2019
Investor News no. 04/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 6 August 2019 Veloxis to Host Conference Call Following Release of Interim Financial Report for the Period 1 January to 30 June 2019 Veloxis [...]
Sanofi : Dupixent® (dupilumab) showed positive topline results in Phase 3 trial of children aged 6 to 11 years with severe atopic dermatitis
06/08/2019
Dupixent ® (dupilumab) showed positive topline results in Phase 3 trial of children aged 6 to 11 years with severe atopic dermatitis U.S. FDA submission for children planned for 4Q 2019 PARIS and TARRYTOWN, NY – August [...]
Sanofi : Dupixent® (dupilumab) a montré des résultats de phase III positifs dans le traitement de la dermatite atopique sévère de l’enfant âgé de 6 à 11 ans
06/08/2019
Dupixent ® (dupilumab) a montré des résultats de phase III positifs dans le traitement de la dermatite atopique sévère de l’enfant âgé de 6 à 11 ans Soumission pour l’enfant auprès de la FDA des États-Unis planifiée [...]
argenx to Present at 2019 Wedbush PacGrow Healthcare Conference
06/08/2019
August 6, 2019 Breda, the Netherlands / Ghent, Belgium – argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the [...]
Sanofi : Dupixent® (dupilumab) approved by European Commission for adolescents with moderate-to-severe atopic dermatitis
06/08/2019
Dupixent ® (dupilumab) approved by European Commission for adolescents with moderate-to-severe atopic dermatitis Only biologic approved in the European Union for patients aged 12 and above with moderate-to-severe atopic [...]
Sanofi : Dupixent® (dupilumab) approuvé par la Commission européenne pour traiter la dermatite atopique modérée à sévère chez les adolescents
06/08/2019
Dupixent ® (dupilumab) approuvé par la Commission européenne pour traiter la dermatite atopique modérée à sévère chez les adolescents Seul médicament biologique approuvé dans l'Union européenne pour le traitement de la [...]
Cosmetic Surgery Institute Celebrates the Launch of Its SkinCeuticals® Flagship Store
06/08/2019
Los Angeles-based plastic surgeons Dr. Mo Zakhireh, Dr. Craig Ball, and their team opened a digital skin care boutique featuring the popular SkinCeuticals® collection PALM DESERT, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE [...]
Chapin Aesthetics Welcomes Distinguished Plastic Surgeon Dr. Noah Prince
06/08/2019
Dr. Scott Chapin and staff are pleased to announce the August arrival of a second physician at the Philadelphia-area Chapin Aesthetics DOYLESTOWN, Pa., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Dr. Noah Prince will be the [...]
Anchiano Therapeutics Reports Second Quarter 2019 Financial Results
05/08/2019
CAMBRIDGE, Mass., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq: ANCN) (“Anchiano”), a pivotal-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat [...]
STERIS Announces Financial Results for Fiscal 2020 First Quarter
05/08/2019
• First quarter revenue grows 9% as reported, 10% constant currency organic revenue growth; • EPS as reported increases to $0.99, adjusted EPS increases to $1.23; • Outlook updated to reflect stronger than anticipated [...]
Voyager Therapeutics to Host Second Quarter 2019 Financial Results and Corporate Highlights Conference Call
05/08/2019
CAMBRIDGE, Mass., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today [...]
Allakos Announces Proposed Public Offering of Common Stock
05/08/2019
REDWOOD CITY, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing AK002 for the treatment of eosinophil and mast cell related diseases, today [...]
Alpha Pro Tech, Ltd. Announces Financial Results for the Second Quarter of 2019
05/08/2019
Building Supply segment sales for the second quarter of 2019 increased by $138,000, or 2.1%, to $6.7 million compared to the second quarter of 2018, driven by a 23.2% increase in roof underlayment sales. Net income for [...]
Teligent, Inc. Announces Second Quarter 2019 Results
05/08/2019
BUENA, N.J., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second quarter ended June 30, 2019 [...]
Bellicum Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Operational Update
05/08/2019
Interim safety and activity data for BPX-601 presented at American Society of Clinical Oncology (ASCO) Annual Meeting Rivo-cel TM achieved primary endpoint in BP-004 European registrational trial HOUSTON, Aug. 05, 2019 [...]
OrthoPediatrics Corp. to Participate in 4th Annual Needham Med Tech & Diagnostics Conference
05/08/2019
WARSAW, Ind., Aug. 05, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that Mark Throdahl [...]
Fulgent Genetics Reports Second Quarter 2019 Financial Results
05/08/2019
Second Quarter 2019 Results : Record billable tests of 16,369, growing 187% year over year Record revenue of $8.4 million, growing 56% year over year Gross Margin improves more than 12 percentage points sequentially; [...]
GenMark Diagnostics Reports Second Quarter 2019 Results
05/08/2019
CARLSBAD, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the [...]
Assembly Biosciences Reports Second Quarter 2019 Financial Results and Recent Highlights
05/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and [...]

Pages